BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights

Go back to BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
(NASDAQ: BTAI) Delayed: 1.15 +0.04 (3.60%)
Previous Close $1.11    52 Week High
Open $1.10    52 Week Low
Day High $1.15    P/E N/A 
Day Low $1.10    EPS
Volume 128,182